Notice of China Resources Shuanghe on convening the 6th Extraordinary General Meeting of Shareholders in 2024
Announcement of China Resources Shuanghe on the Company\'s 2021 Restricted Stock Incentive Plan to reserve and grant some of the first achievements to lift the sales restriction conditions during the period of lifting the sales restrictions
Announcement of China Resources Shuanghe on the changes of directors, president and legal representative
Announcement of Resolutions of the Fourth Meeting of the 10th Board of Supervisors of China Resources Shuanghe
Announcement of China Resources Shuanghe on the main operating data for the 1st to 3rd quarter of 2024
Announcement of Resolutions of the Fourth Meeting of the 10th Board of Directors of China Resources Shuanghe
China Resources Shuanghe 2024 Third Quarter Report
China Resources Shuanghe\'s announcement on the progress of the 2024 “Improve Quality, Increase Efficiency, and Value Return” action plan
China Resources Shuanghe Company\'s “Articles of Association” (revised by the 4th meeting of the 10th board of directors on October 25, 2024)
Announcement of China Resources Shuanghe on changing the registered capital and amending the company\'s “Articles of Association”
China Resources Shuanghe Supervisory Board\'s Inspection Opinions on Matters Related to the 2021 Restricted Stock Incentive Plan
Legal Opinion of Beijing Zhonglun Law Firm on the Reserved Part of China Resources Shuanghe\'s 2021 Restricted Stock Incentive Plan, Release the Sales Restriction Period, Achievements, and Repurchase and Cancellation of the Restricted Shares that have been granted but have not yet been lifted
China Resources Shuanghe\'s announcement on the company\'s repurchase and cancellation of some restricted stocks that have been granted incentives but sales restrictions have not yet been lifted
China Resources Double-Crane Pharmaceutical's announcement regarding the third quarter performance briefing for 2024.
Announcement of China Resources Shuanghe on the approval notice for sildenafil citrate tablets from its wholly-owned subsidiary China Resources Secco Pharmaceutical Co., Ltd.
China Resources Shuanghe: China Resources Shuanghe\'s Announcement on Changing the Secretary of the Board
China Resources Shuanghe: Announcement of Resolutions of the Third Meeting of the 10th Board of Directors of China Resources Shuanghe
Announcement of Resolutions of the Third Meeting of the 10th Board of Directors of China Resources Shuanghe
Announcement of China Resources Shuanghe on changing the secretary of the board
Announcement of Resolutions of the Third Meeting of the 10th Board of Supervisors of China Resources Shuanghe
No Data
No Data